Liraglutide in an adolescent population with obesity: a randomized, double-blind, placebo-controlled 5-week trial to assess safety, tolerability, and pharmacokinetics of liraglutide in adolescents aged 12-17 years
An actin gene was included as a reference gene (internal control)
There was no significant difference in the permeability of 3-PLG-dopa-A-GSH between the control and the PD organoid groups
Pharmacological characterization To examine whether the potent weight loss observed in vivo after GLP-1MK-801 treatment is attributable to pharmacological synergy between GLP-1 and MK-801 or consequential to altered pharmacokinetic properties of the parent GLP-1 analogue, we designed and synthesized a conjugate comprising an inactive MK-801 surrogate 22 (Supplementary Fig
Mitsui, S., Saito, M., Mori, K
sourcing and administering it safely is the other